A Sequencer for the LHC ERA

The Sequencer is a high level software application that helps operators and physicists to commission and control the LHC. It is an important operational tool for the LHC and a core part of the control system that interacts with all LHC sub-systems. This paper describes the architecture and design of the sequencer and illustrates some innovative parts of the implementation, based on modern Java technology

ASSOCIATION OF LACTOFERRIN WITH SPECIFIC GRANULES IN RABBIT HETEROPHIL LEUKOCYTES

Lactoferrin has been identified in rabbit heterophil leukocytes on the basis of its immunological reactivity, electrophoretic mobility, acid-resistant iron-binding properties, and spectral characteristics. Leukocyte lactoferrin was found to be exclusively localized in the specific (secondary) granules, which have been resolved from other subcellular components by zonal differential centrifugation and by isopycnic equilibration

METHOTREXATE ACTION IN RHEUMATOID ARTHRITIS: STIMULATION OF CYTOKINE INHIBITOR AND INHIBITION OF CHEMOKINE PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS

This open label study examines whether methotrexate (MTX) treatment modulates ex vivo synthesis of interleukin-1 receptor antagonist (IL-lra), soluble tumour necrosis factor receptors(sTNFR p55 and p75), interleukin-1β (IL-1β), tumour necrosis factor α(TNF-α), interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) by peripheral blood mononuclear cells (PBMC} and whether changes reflect clinical response. Significant stimulation of IL-lra and sTNFR p75 as well as inhibition of IL-8 production of PBMC were associated with clinical improvement observed in patients treated with MTX. When defining the characteristics of patients at study entry retrospectively in responders and non-responders a significantly lower ratio of IL-lra :IL-1β production before and its increase upon treatment was associated with clinical response in 13 patients compared to five patients not responding to MTX. In addition, clinical improvement was associated with decreased synthesis of IL-1β, TNF-α and IL-8 induced by bacterial lipopolysaccharide, IL-1α and IL-1β in PBMC in vitro. These findings suggest that MTX therapy reverses the inflammatory type of rheumatoid arthritis (RA) blood mononuclear cells by stimulating cytokine inhibitor production while inhibiting inflammatory cytokine release at the same time. This may explain the powerful anti-inflammatory properties of low-dose MTX as observed in most RA patients. Pretreatment determination of the IL-lra: IL-1β ratio in PBMC may be predictive with regard to a favourable therapeutic response and therefore may be useful for the selection of RA patients to be treated with MT

Stereocontrolled Total Synthesis of 1a,25-Dihydroxyergocalciferol

A stereocontrolled total synthesis of the vitamin D2metabolite 1a,25-dihydroxyergocalciferol (1), which involves a coupling of the previously described A ring synthon 2 with the appropriately functionalized C-D moiety 3, is described. In the key step, stereochemical control is achieved by taking advantage of the thermal reversibility of a [3+ 2]-cyc1oaddition of methyl 0,~-dimethylacrylate and the C-D C-23 nitrone 4 to effect conversion to the C-24S isoxazolidinecarboxylic acid methyl ester Sa, which is readily transformed by reduction followed by elimination of the nitrone function into the necessary C-D precursor

Experience with the LHC beam dump post-operational checks system

After each beam dump in the LHC automatic post-operational checks are made to guarantee that the last beam dump has been executed correctly and that the system can be declared to be ‘as good as new’ before the next injection is allowed. The analysis scope comprises the kicker waveforms, redundancy in kicker generator signal paths and different beam instrumentation measurements. This paper describes the implementation and the operational experience of the internal and external post-operational checks of the LHC beam dumping system during the commissioning of the LHC without beam and during the first days of beam operation